Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System

E-ISSN： 1532-6535|93|6|539-546

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.6, 2013-06, pp. : 539-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular and pulmonary adverse events in patients treated with BCR‐ABL inhibitors: Data from the FDA Adverse Event Reporting System

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : E66-E72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 1, 2015-07 ,pp. : 52-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developing a Comprehensive Electronic Adverse Event Reporting System in an Academic Health Center

By Kivlahan Coleen Sangster William Nelson Kathryn Buddenbaum Jennifer Lobenstein Kenneth

Joint Commission Journal on Quality and Patient Safety, Vol. 28, Iss. 11, 2002-11 ,pp. : 583-594

Joint Commission Resources

Access to resources Recommend Favorite

Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS)

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 9, 2015-09 ,pp. : 922-933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite